Oruka Therapeutics, Inc. (ORKA): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$15.0K
Year ended 2023-12-31
+23.3%
3-year compound annual growth
-7.4%
5-year compound annual growth
-5.4%
10-year compound annual growth
$602.0K2010-12-31: $338.0K2011-12-31: $602.0K2012-12-31: $43.0K2013-12-31: $26.0K2014-12-31: $12.0K2015-12-31: $19.0K2016-12-31: $24.0K2017-12-31: $27.0K2018-12-31: $22.0K2019-12-31: $18.0K2020-12-31: $8.0K2021-12-31: $16.0K2022-12-31: $20.0K2023-12-31: $15.0K$15.0K
2010-12-31 Depreciation & Amortization (USD) 2023-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2023-12-31$15.0K-25.0%2024-02-01, From 2023-01-01
2022-12-31$20.0K+25.0%2024-02-01, From 2022-01-01
2021-12-31$16.0K+100.0%2023-02-24, From 2021-01-01
2020-12-31$8.0K-55.6%2022-03-14, From 2020-01-01
2019-12-31$18.0K-18.2%2021-03-18, From 2019-01-01
2018-12-31$22.0K-18.5%2020-02-18, From 2018-01-01
2017-12-31$27.0K+12.5%2019-02-27, From 2017-01-01
2016-12-31$24.0K+26.3%2018-03-22, From 2016-01-01
2015-12-31$19.0K+58.3%2017-03-21, From 2015-01-01
2014-12-31$12.0K-53.8%2016-03-17, From 2014-01-01
2013-12-31$26.0K-39.5%2015-03-19, From 2013-01-01
2012-12-31$43.0K-92.9%2014-03-20, From 2012-01-01
2011-12-31$602.0K+78.1%2013-03-21, From 2011-01-01
2010-12-31$338.0Kn/a2012-03-27, From 2010-01-01